Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+73.8%
5Y CAGR+35.6%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+73.8%/yr
Annual compound
5Y CAGR
+35.6%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.6x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $51.61M | +228.9% |
| 2024 | $-40.04M | +32.4% |
| 2023 | $-59.21M | -702.1% |
| 2022 | $9.83M | -62.8% |
| 2021 | $26.46M | +135.5% |
| 2020 | $11.24M | +5230.6% |
| 2019 | $-219000.00 | -5.3% |
| 2018 | $-208000.00 | -148.9% |
| 2017 | $425000.00 | -98.6% |
| 2016 | $29.98M | - |